Peter Crosby brings more than 40 years of leadership in the medical technology and life sciences sectors, having established himself as a preeminent figure in bringing innovative implantable devices to global markets. He has served as chief executive of six medical device companies in four countries and directed numerous others across multiple geographies. Crosby holds a degree in Biomedical Engineering (M Eng Sci) from the University of Melbourne, with early career work in engineering research and development.
Crosby's career achievements are substantial. As part of the founding team of Cochlear, the global leader in implantable hearing prostheses, he went on to found and lead Euronext-listed Mainstay Medical, a neurostimulation company through its 2014 initial public offering. Over his career, he has raised more than $200 million in public and private capital and brought numerous implantable devices to market. He is an inventor on over 50 US patents and applications, and has managed intellectual property for several companies.
Career History
- Founder and CEO of Mainstay Medical (neurostimulation), taken public on Euronext 2014
- CEO of Ventracor (left ventricular assist devices)
- President & CEO of Cardiocomm Solutions Inc and NeoVision Corporation
- CEO of Ausonics and Ischemia Technologies
- Founding team member of Cochlear
What Peter Crosby could bring to Tensive S.r.l.: Crosby's appointment as Chairman reflects the company's transition to a commercial-stage enterprise. His proven track record in guiding multiple medical device companies through regulatory approval pathways (FDA 510(k), PMA, and CE Mark) directly aligns with Tensive's imminent regulatory milestones. His strategic insight and deep governance experience will be crucial advantages as Tensive advances its first device into regulatory processes for marketing approval and commercialization in the U.S. His capital-raising expertise and international launch experience position him to accelerate market entry for REGENERA™/SOFTAG™ in both European and U.S. markets.
This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.
Facts compiled by Executive Moves from publicly available news and press releases on 8 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you Peter Crosby?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →





